Merck loses bid to revive $200 million Gilead verdict at U.S. high court

The U.S. Supreme Court on Monday handed a defeat to Merck & Co by refusing to he...

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Reuters /  🏆 2. in US

Australia Latest News, Australia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Fintech start-up Plaid to buy competitor Quovo for $200 million in its first major dealFintech start-up Plaid is buying competing data company Quovo for $200 million.
Read more »

Shutdown effect on federal contractors: $200 million a week at riskThe partial shutdown threatens an untold legion of workers in private companies that do business with affected agencies.
Read more »

Bill Gates: My 'best investment' turned $10 billion into $200 billion worth of economic benefitInvesting in global health organizations aimed at increasing access to vaccines creates a 20-to-1 return, the Microsoft co-founder and philanthropist says.
Read more »

U.S. Supreme Court could side with Merck over Fosamax lawsuitsU.S. Supreme Court justices on Monday appeared sympathetic to Merck & Co in its ...
Read more »

Supreme Court to decide if Fosamax users can sue Merck over bone fracturesThe Supreme Court will hear arguments in a case brought by more than 500 Fosamax users from 45 states trying to sue drug-maker Merck over spontaneous fractures.
Read more »